Vulvodynia in Indian Women: Causes, Diagnosis & Treatment

• Vulvodynia means vulvar pain lasting 3+ months with no identifiable cause — it is a real neuropathic pain condition, not 'all in your head'.
• There are two main patterns: provoked vestibulodynia (sharp, burning pain on touch at the vaginal opening) and generalised unprovoked vulvodynia (constant burning across a wider area).
• Repeated antifungal creams and antibiotics that never work are a red flag that the problem may be vulvodynia, not infection.
• The most effective treatments combine pelvic floor physiotherapy, topical agents, low-dose oral nerve-pain medicines, and sex therapy — most women improve substantially.
• If your pain has been dismissed, you can ask for a referral to a urogynaecologist or pelvic pain specialist; you deserve a proper diagnosis.

Vulvodynia is chronic vulvar pain lasting at least three months with no identifiable cause. It is a diagnosis of exclusion — infection has been ruled out, skin conditions like lichen sclerosus, lichen planus and contact dermatitis have been ruled out, nerve lesions have been excluded, and there is no obvious structural problem. What remains is pain that is real, often severe, and not explained by anything visible. The International Society for the Study of Vulvovaginal Disease (ISSVD) defines vulvodynia formally and groups it by location (localised vs generalised) and by what triggers it (provoked vs spontaneous).

Localised provoked vulvodynia — also called vestibulodynia — is the most common type. The pain sits at the vestibule, the small area just inside the vaginal opening, and is triggered specifically by touch: attempted sex, tampon insertion, a speculum exam, sometimes tight clothing or sitting. Left untouched, the area is pain-free. Women often describe sharp, burning, stinging pain or a sensation 'like cuts'. Many have had painful sex from the very first attempt, or pain that began after a trigger such as a recurrent yeast infection, surgery, childbirth, or starting a hormonal contraceptive.

Generalised unprovoked vulvodynia is constant or near-constant burning and irritation across a wider area of the vulva, often present at rest and without a clear touch trigger. Women describe it as 'sitting on broken glass', 'a constant raw burning', or 'a UTI that never goes away'. The two patterns can overlap. The pain is neuropathic (nerve-type) in character and shares biology with other chronic pain conditions — many women with vulvodynia also live with Fibromyalgia in Indian Women: Real Pain, Diagnosis and Treatment, interstitial cystitis, or irritable bowel syndrome.

The biggest barrier is cultural silence around anything vulvar or sexual. Many Indian women do not discuss vulvar pain even with close female relatives, delay seeking help for years, and when they do see a doctor, often understate the severity — using vague words, avoiding the topic, downplaying the impact on their lives. The lingering idea that women's pain is exaggerated or 'in the head' makes this worse. Partners may not be told the full picture, and an older generation that never had a name for the condition often has no way to make sense of it.

A medical training gap adds to the problem. Many GPs, gynaecologists and even some specialists are not familiar with vulvodynia as a specific diagnosis. Women with vulvar pain are commonly given repeated courses of antifungal cream (assumed yeast), antibiotics (assumed bacterial vaginosis or UTI), or steroids (assumed dermatitis), without the focused examination that would identify vulvodynia. The diagnostic skills — cotton-swab testing to map the pain, ruling out specific conditions, taking a careful pain history — are teachable but under-taught in many Indian curricula. The result is years of treatment that never works. Recurrent yeast-like symptoms that never settle deserve a rethink, which is why distinguishing true infection matters; our guide to Vulvovaginitis: Types, Symptoms and Treatment for Indian Women explains how the real causes are told apart.

Structural barriers exist too. Multidisciplinary vulvar-pain clinics — combining urogynaecology, pain medicine, pelvic floor physiotherapy and sex therapy — are concentrated in a few large cities and scarce in smaller towns. Travel and time costs are real. The under-recognition then feeds itself: because few women are diagnosed, awareness stays low, and more women keep suffering without a name for what is happening. Better professional training and more public awareness are slowly changing this through urogynaecology societies, women's-health advocates and patient communities.

Diagnosis is clinical and follows a structured assessment by a clinician familiar with the condition. The history explores the pain in detail — when it started, what makes it better or worse, whether it is provoked by touch or constant, its location and quality (burning vs aching vs sharp), and any linked symptoms like urinary urgency, painful sex, or pain with sitting. Sexual, menstrual, contraceptive, childbirth and surgical history all matter, because each can point to a contributing cause.

Examination focuses on the external genitalia and the vestibule. The skin is inspected for any visible abnormality — lichen sclerosus (white, thinned skin), lichen planus, contact dermatitis, atrophy after menopause, scarring or signs of infection. A small speculum may be used if tolerated. The cotton-swab test — gentle touch with a moistened swab at set points around the vestibule and vulva — maps the tenderness; vestibulodynia typically shows exquisite tenderness at specific points with normal sensation elsewhere. The pelvic floor muscles are then assessed by gentle internal examination for tone, tenderness and trigger points.

Investigations rule out other causes: a vaginal swab and microscopy to exclude yeast, bacterial vaginosis and trichomoniasis; a urine culture to exclude a bladder infection (see our guide to acute cystitis); and pH testing. Hormone levels or a small skin biopsy are added only if a specific cause is suspected. The diagnosis of vulvodynia is reached when the typical pain pattern is present, examination shows the characteristic tenderness, and other causes have been excluded. Getting the label matters — it gives the pain a name, confirms it is real, and opens the door to targeted treatment. AIIMS Delhi's urogynaecology unit, members of the Urogynecological Association of India, and a small number of dedicated vulvar-pain clinics are where this diagnostic skill is most reliably available.

Topical treatments are usually the first step because they target the painful area directly and can give meaningful relief while longer-term measures take effect. Topical lignocaine (lidocaine) is the most widely used. A 2–5% gel or ointment applied to the painful vestibule before sex or any provoking activity gives several hours of local numbing that can make intercourse possible (with communication and consent) or ease tampon use. Overnight use under a small cotton pad has been studied with mixed results — it helps some women, not others. Indian brands such as Xylocaine, Lox and Lignox are sold widely, roughly ₹50–200 a tube.

Topical oestrogen helps when there is co-existing menopausal thinning of the tissue, or in younger women on combined hormonal contraception that has lowered local oestrogen and testosterone. Estriol cream or a conjugated-oestrogen vaginal cream, applied to the vestibule nightly for two weeks then twice weekly, restores the tissue and reduces pain. If dryness is a big part of your picture, our guides to vaginal dryness causes and treatments and vaginal atrophy in menopause go deeper. A compounded testosterone cream is used in some women with low testosterone contributing to vestibulodynia.

Other options include compounded amitriptyline 2% cream or gabapentin 6% cream (topical nerve-pain agents), capsaicin cream (which burns at first then dulls pain, and is not tolerated by everyone), and a topical steroid if there is concurrent skin inflammation. Creams should be applied precisely to the area of pain — the vestibule, not deep into the vagina — and your clinician should guide the technique. Topical agents resolve symptoms in some women; in others they are one part of a broader plan.

Pelvic floor physiotherapy is one of the most effective treatments for vulvodynia and is dramatically under-used in India. The majority of women with vulvodynia have pelvic floor muscle dysfunction — overly tight (hypertonic) muscles, trigger points, poor coordination and protective guarding — all of which feed the pain. A women's-health physiotherapist trained in pelvic pain can reduce the pain and improve function in most women, often substantially.

Assessment includes external pelvic and lower-abdominal muscle checks and, with consent, a gentle internal examination to assess muscle tone, tenderness and trigger points. Treatment is individualised but usually combines manual therapy to release tight muscles, stretching, breathing and relaxation training (the opposite of strengthening — the goal is to teach over-active muscles to let go), and graded use of vaginal dilators to slowly reduce sensitivity. Biofeedback gives visual or sound cues of muscle activity so women can learn to consciously relax. Note that this is different from strengthening work — if you have read about Kegel exercises for sexual health, vulvodynia usually calls for down-training, not more squeezing.

A typical course is six to twelve sessions over two to four months, with real improvement expected in most women. The physiotherapist coordinates with the gynaecologist or pain specialist on medication and may weave in sex-therapy elements such as lubrication, non-penetrative intimacy and partner communication. Pelvic floor physiotherapy units are growing across Indian metros, including dedicated private clinics, with sessions roughly ₹500–2,500 in private settings and subsidised in government hospitals. Hesitation about internal examination is the biggest barrier, but assessments are done with full consent, usually by a female physiotherapist, and most women find the experience professional and the treatment genuinely helpful. Our guide to postpartum pelvic floor rehab covers the broader approach.

Oral medicines for vulvodynia work on the nerve-pain pathway rather than on infection or inflammation, reflecting the neuropathic nature of the pain. Low-dose tricyclic antidepressants are the most established — used at doses far lower than those for depression. Amitriptyline 10–75 mg at bedtime (starting at 10 mg and increasing slowly over weeks as tolerated) dampens nerve-pain signalling and has good evidence in vulvodynia. Side effects include drowsiness (often helpful at night), dry mouth, constipation and some weight gain; nortriptyline has fewer side effects and suits some women better. Indian brands (Tryptomer, Amitone for amitriptyline; Sensoval for nortriptyline) are inexpensive, around ₹50–200 a month.

Anticonvulsants also have evidence. Gabapentin starts at 100–300 mg three times daily and is titrated up as tolerated; pregabalin is 75–150 mg twice daily. Side effects include drowsiness, dizziness and sometimes weight gain. These are usually second-line after tricyclics, or added if a tricyclic alone is not enough. Indian brands (Gabapin, Gabantin for gabapentin; Pregaba for pregabalin) cost roughly ₹200–1,000 a month.

Other options include duloxetine (an SNRI used for chronic pain). Opioids are generally avoided for chronic vulvodynia because of long-term risks and limited evidence. Treating co-existing conditions matters too — if there is depression, anxiety, fibromyalgia, irritable bowel syndrome or interstitial cystitis, addressing these improves the overall pain picture. Coordination between gynaecologist, pain specialist, mental-health support and physiotherapist is the model of care for moderate-to-severe vulvodynia, and most women need a combination of approaches rather than a single drug.

Sex therapy and emotional support are essential parts of vulvodynia care, because the condition affects intimate relationships and wellbeing, and because pain is always shaped by anxiety, expectation and coping. The aim is never to dismiss the pain as psychological — vulvodynia is a real condition with real biology — but to support the emotional and relational layers that interact with it.

Sex therapy with a trained counsellor addresses several things: open communication with a partner about what is and is not possible; expanding intimacy beyond penetration through sensate-focus exercises and non-penetrative pleasure; and easing the anticipatory anxiety that builds after repeated painful experiences, because fear and tensing make pain worse. It also helps with co-existing Vaginismus: Causes, Symptoms and Treatment for Indian Women — the involuntary pelvic floor spasm at attempted penetration that often develops in women with vestibulodynia. Restoring desire matters too; our guide to increasing female libido and tips on choosing the right lubricant during sex can both help.

Beyond sex therapy, broader psychological support is valuable for many women. Cognitive behavioural therapy for chronic pain, acceptance and commitment therapy, and mindfulness-based stress reduction all have evidence in chronic pain, including vulvodynia. Co-existing depression and anxiety should be screened for and treated. Peer support — connecting with other women through online communities — reduces isolation. Indian options range from free helplines such as iCALL (TISS) to telehealth therapy and in-person sex-therapy practices in major cities, with paid sessions roughly ₹1,500–5,000.

Vulvodynia often travels with other chronic pain conditions, and treating them together improves outcomes. Vaginismus frequently develops as a protective response in women with vestibulodynia and becomes a problem in its own right; physiotherapy, dilators and sex therapy are the standard. Interstitial cystitis (painful bladder syndrome — chronic bladder pain with urinary frequency and urgency without infection) overlaps in many women and responds to bladder retraining, avoiding bladder irritants such as caffeine, alcohol, citrus and very spicy food, and medicines like amitriptyline.

Fibromyalgia, chronic fatigue and irritable bowel syndrome are recognised companions — they share features of central pain sensitisation and respond to similar approaches, and treating them eases the overall pain. Migraine is also more common in women with vulvodynia. Endometriosis can co-exist and add to deeper pelvic pain; if periods or deep pain are part of your picture, see our guides to endometriosis pain management and painful periods (dysmenorrhea).

Hormonal factors deserve attention. Menopausal genitourinary changes cause vestibular thinning that can mimic vulvodynia, and topical oestrogen treats this directly. Younger women on combined hormonal contraception sometimes develop symptoms tied to lowered local hormones — a conversation with the gynaecologist about alternatives, or topical oestrogen and testosterone, can help. Mental-health conditions often co-exist with chronic pain, and treating them improves pain outcomes. The principle is simple: vulvodynia is rarely an isolated problem, and comprehensive care works best.

Surgical and advanced treatments are reserved for severe vulvodynia — particularly vestibulodynia — that has not responded to conservative measures including topical agents, pelvic floor physiotherapy, oral medicines and sex therapy. Vestibulectomy is the surgical removal of the painful vestibular tissue, with reapproximation of the vaginal mucosa to the perineum. In carefully selected women with clearly localised vestibulodynia who have not improved otherwise, most series report a 60–80% reduction in pain and meaningful gains in sexual function. Selection depends on pain that maps clearly to the vestibule on cotton-swab testing, failure of conservative care, and a stable psychosocial situation.

Botulinum toxin (Botox) injection into the pelvic floor muscles is used when there is significant muscle tightness. Around 100–300 units injected into specific muscle sites under guidance reduces tension and pain for several months, with repeat injections often needed every 6–12 months. It is available at urogynaecology centres in major hospitals, with costs around ₹20,000–60,000 per session including the toxin and procedure.

Other specialised options — sacral nerve stimulation, pulsed radiofrequency of the pudendal nerve, and nerve blocks — are available only at a few pain centres in India. Multidisciplinary pain clinics at AIIMS, KEM Mumbai and large private hospitals can coordinate these for refractory cases. The decision for advanced or surgical treatment is made only after a thorough trial of conservative care and detailed assessment by a specialist with vulvodynia expertise. Most women improve substantially with conservative care and never need surgery — the option exists for the small group who do.

Care ranges from an accessible first evaluation to specialist multidisciplinary management at large centres. A GP or general gynaecology consultation costs roughly ₹300–1,500 and is a reasonable first contact, though many GPs do not recognise vulvodynia and may treat empirically. A urogynaecologist consultation at large private hospitals costs around ₹800–3,000 for initial assessment, with vulvodynia-aware centres concentrated in major cities. Telehealth consultations through platforms such as Practo or Apollo 24/7 cost around ₹200–1,200 and can be a comfortable first step.

Investigations are usually inexpensive: a vaginal swab and microscopy roughly ₹300–1,000, urine culture ₹400–1,200, pH testing ₹100–300, and a skin biopsy if needed ₹800–3,000. On the treatment side: topical lignocaine gel ₹50–200 a tube, topical oestrogen cream ₹300–1,200 a tube, oral amitriptyline ₹50–200 a month, gabapentin ₹200–1,000 a month, pregabalin ₹400–1,500 a month, pelvic floor physiotherapy ₹500–2,500 a session (typically 6–12 sessions), and sex therapy ₹1,500–5,000 a session. Botox for the pelvic floor runs ₹20,000–60,000, and vestibulectomy ₹50,000–2,00,000 in private hospitals, far less in government settings.

Centres known for vulvodynia and pelvic-floor care include AIIMS Delhi urogynaecology, members of the Urogynecological Association of India, large private hospital networks, and dedicated pelvic-floor physiotherapy clinics in metros. Government schemes such as Ayushman Bharat, ESI and CGHS cover most costs for eligible patients. For women in smaller cities, an online consultation with a specialist for the diagnostic workup and plan, followed by a local GP for prescriptions and follow-up, is a workable model. The investment in a proper diagnosis is usually far less than the cost — financial and emotional — of years of treatments that never worked.

See a clinician — ideally one who knows vulvodynia, such as a urogynaecologist or pelvic pain specialist — if any of the following apply to you. Early, accurate diagnosis spares you years of treatments that do not work.

• ACOG – Vulvodynia (Frequently Asked Questions)
• RCOG / British Society for the Study of Vulval Disease – Vulval Pain (Vulvodynia) Guidance
• NHS – Vulvodynia (Vulval Pain)
• International Society for the Study of Vulvovaginal Disease (ISSVD)